Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
NRX Pharmaceuticals (NRXP)
NASDAQ:NRXP
Holding NRXP?
Track your performance easily
NRXP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.10 - $7.33
Previous Close$1.26
Volume648.05K
Average Volume (3M)127.09K
Market Cap
$15.24M
Enterprise Value$20.26M
Total Cash (Recent Filing)$1.65M
Total Debt (Recent Filing)$6.67M
Price to Earnings (P/E)―
Beta1.93
Next Earnings
Mar 27, 2025EPS Estimate
-$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.15
Shares Outstanding12,094,094
10 Day Avg. Volume176,136
30 Day Avg. Volume127,095
Standard Deviation0.29
R-Squared0.11
Alpha-0.09
Financial Highlights & Ratios
Price to Book (P/B)-0.78
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.03
Forecast
1Y Price Target
$37.50Price Target Upside2762.60% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
NRX Pharmaceuticals News
PremiumCompany Announcements
NRX Pharmaceuticals Strengthens Leadership with New CFO Appointment
PremiumCompany Announcements
NRx Pharmaceuticals Reports Progress in Drug Development
PremiumCompany Announcements
NRX Pharmaceuticals Advances in Mental Health Sector
Ownership Overview
―
Insiders
2.57% Mutual Funds
2.67% Other Institutional Investors
90.25% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NRXP FAQ
What was NRX Pharmaceuticals’s price range in the past 12 months?
NRX Pharmaceuticals lowest stock price was $1.10 and its highest was $7.33 in the past 12 months.
What is NRX Pharmaceuticals’s market cap?
Currently, no data Available
When is NRX Pharmaceuticals’s upcoming earnings report date?
NRX Pharmaceuticals’s upcoming earnings report date is Mar 27, 2025 which is in 121 days.
How were NRX Pharmaceuticals’s earnings last quarter?
NRX Pharmaceuticals released its earnings results on Nov 14, 2024. The company reported -$0.15 earnings per share for the quarter, beating the consensus estimate of -$0.555 by $0.405.
Is NRX Pharmaceuticals overvalued?
According to Wall Street analysts NRX Pharmaceuticals’s price is currently Undervalued.
Does NRX Pharmaceuticals pay dividends?
NRX Pharmaceuticals does not currently pay dividends.
What is NRX Pharmaceuticals’s EPS estimate?
NRX Pharmaceuticals’s EPS estimate is -$0.42.
How many shares outstanding does NRX Pharmaceuticals have?
NRX Pharmaceuticals has 12,094,094 shares outstanding.
What happened to NRX Pharmaceuticals’s price movement after its last earnings report?
NRX Pharmaceuticals reported an EPS of -$0.15 in its last earnings report, beating expectations of -$0.555. Following the earnings report the stock price went up 2.586%.
Which hedge fund is a major shareholder of NRX Pharmaceuticals?
Among the largest hedge funds holding NRX Pharmaceuticals’s share is Owl Creek Asset Management, L.P.. It holds NRX Pharmaceuticals’s shares valued at N/A.
---
NRX Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$37.50 (2762.60% Upside)
$37.50 (2762.60% Upside)
Hedge Fund Trend
Decreased
By 5.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days >0.1%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.76%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-65.96%
Trailing 12-Months
Company Description
NRX Pharmaceuticals
Big Rock Partners Acquisition Corp. is a blank check company, which was formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, reorganization, recapitalization or other similar business combination with one or more businesses or entities. It focuses on identifying a prospective target business in the senior housing and care industry in the United States. The firm's care segments are commonly divided into four categories: Independent Living; Assisted Living; Memory Care and Nursing Care. The company was founded on September 18, 2017 and is headquartered in Delray Beach, FL.
---
NRXP Earnings Call
Q3 2024
0:00 / 0:00
---
NRXP Stock 12 Month Forecast
Average Price Target
$37.50
▲(2762.60% Upside)
Technical Analysis
Best Analysts Covering NRXP
1 Year
1 Year Success Rate
0/8 ratings generated profit
1 Year Average Return
-43.46%
reiterated a buy rating 3 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -43.46% per trade.
---